Related Experiment Videos

p27: a pleiotropic regulator of cellular phenotype and a target for cell cycle dysregulation in cancer

C Desdouets1, C Bréchot

  • 1Inserm U370, Paris, France.

Pathologie-Biologie
|June 20, 2000
PubMed

Insights

The cyclin-dependent kinase inhibitor p27 regulates cell growth and illustrates complex biological effects in normal and cancer cells. This review details its role as a negative regulator of cell proliferation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The eukaryotic cell cycle is controlled by cyclin-dependent kinases (CDKs).
  • CDK activity is modulated by phosphorylation and regulatory subunits like cyclins and CDK inhibitors.
  • The cyclin-dependent kinase inhibitor p27 is a key negative regulator of cell growth.

Purpose of the Study:

  • To review the multifaceted role of the cyclin-dependent kinase inhibitor p27.
  • To highlight the complex regulatory mechanisms governing p27 function.
  • To illustrate the pleiotropic effects of p27 in normal and cancerous cells.

Main Methods:

  • Literature review of recent research on p27.
  • Analysis of regulatory mechanisms of CDK activity.
  • Examination of p27's biological effects in various cellular contexts.

Main Results:

  • p27 acts as a crucial negative regulator of cell proliferation.
  • p27 exhibits diverse biological effects beyond cell cycle inhibition.
  • The regulation of p27 involves intricate molecular interactions and pathways.

Conclusions:

  • The cyclin-dependent kinase inhibitor p27 plays a significant role in cell growth regulation.
  • Understanding p27's complex functions is vital for both normal physiology and cancer research.
  • Further investigation into p27 regulatory mechanisms can reveal therapeutic strategies.

Related Concept Videos